22 Nov 2023 , 03:44 PM
Dr Reddy’s Laboratories, Glenmark Pharma, and Zydus are recalling products in the US market due to manufacturing issues, as per the US Food and Drug Administration (USFDA).
The recalls are classified as Class II, where the use or exposure to the violative product may cause temporary or medically reversible adverse health consequences, with a remote probability of serious adverse health consequences, according to the USFDA.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.